Circulating hTERT mRNA as a tumor marker in cholangiocarcinoma patients

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 26

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

251

HTML

1802

Figures (1-1)

192

Tables (1-3)

156

Sum=2401

Jul 14, 2006 (publication date) through Nov 4, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Jul 14, 2006; 12(26): 4195-4198
Published online Jul 14, 2006. doi: 10.3748/wjg.v12.i26.4195

Table 1 The patient demographic data and blood chemistry data

	Benign biliary tract disease	Cholangio-carcinoma	Healthyvolunteers
Sex (Male:Female)	21:20	19:14	6:4
Age (year), (median)	53.68 (22-82)	56.40 (35-85)	49.50 (26-60)
SGOT (IU/dL)	105.32 ± 52.26	112.52 ± 44.54	30.20 ± 12.20
SGPT (IU/dL)	96.04 ± 45.42	73.41 ± 44.30	28.50 ± 9.22
Total Bilirubin (mg/dL)^a	3.8 ± 2.21	12.8 ± 5.24	1.05 ± 0.25
Alkaline Phosphatase (U/dL)^a	309 ± 67.53	550 ± 24.44	98 ± 10.60

^aP < 0.005.

Citation: Leelawat K, Leelawat S, Ratanachu-Ek T, Trubwongchareon S, Wannaprasert J, Tripongkaruna S, Chantawibul S, Tepaksorn P. Circulating hTERT mRNA as a tumor marker in cholangiocarcinoma patients. World J Gastroenterol 2006; 12(26): 4195-4198
URL: https://www.wjgnet.com/1007-9327/full/v12/i26/4195.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i26.4195